Passport Capital’s Gilead Sciences GILD Stock Holding History

Passport Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,000,000	Closed	-$396M	–	117
2016 Q3	$396M	Buy	+5,000,000	New	+$406M	8.19%	2

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Passport Capital's GILD Position: Q4 2016 in Review

Passport Capital sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,224 shares — an estimated $255K sold.

Passport Capital first reported a position in GILD in Q1 2014 and held it in 9 quarters. The position peaked at $60.9M in Q2 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Passport Capital reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Passport Capital sold 3,224 Gilead Sciences shares in Q4 2016, an estimated $255K.
Passport Capital first reported a position in Gilead Sciences in Q1 2014 and held it in 9 quarters.
Passport Capital's Gilead Sciences position peaked at $60.9M in Q2 2016.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Passport Capital's 13F filing for Q4 2016, filed 14 Feb 2017.